Incannex Healthcare Files 8-K
Ticker: IXHL · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, sec-filing
TL;DR
INCANNEX files 8-K, check for updates.
AI Summary
Incannex Healthcare Inc. filed an 8-K on August 5, 2024, reporting other events and financial statements. The filing details the company's principal executive offices located in Norwest, NSW, Australia, and confirms its incorporation in Delaware. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing serves as a notification to the SEC and investors about significant corporate events or financial updates for Incannex Healthcare Inc.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not inherently present new risks based on the provided information.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- August 5, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-41106 (company_id) — SEC File Number
- 93-2403210 (company_id) — IRS Employer Identification No.
- +61 409 840 786 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting 'Other Events' and 'Financial Statements and Exhibits'.
When was this report filed?
The report was filed on August 5, 2024.
Where are Incannex Healthcare Inc.'s principal executive offices located?
The principal executive offices are located at Suite 105, 8 Century Circuit, Norwest, NSW 2153, Australia.
In which state is Incannex Healthcare Inc. incorporated?
Incannex Healthcare Inc. is incorporated in Delaware.
What is the SEC file number for Incannex Healthcare Inc.?
The SEC file number for Incannex Healthcare Inc. is 001-41106.
Filing Stats: 438 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-08-05 08:15:26
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
Filing Documents
- ea0210597-8k_incannex.htm (8-K) — 27KB
- ea021059701ex99-1_incannex.htm (EX-99.1) — 20KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- 0001213900-24-065003.txt ( ) — 239KB
- ixhl-20240805.xsd (EX-101.SCH) — 3KB
- ixhl-20240805_lab.xml (EX-101.LAB) — 33KB
- ixhl-20240805_pre.xml (EX-101.PRE) — 22KB
- ea0210597-8k_incannex_htm.xml (XML) — 4KB
01
Item 8.01 On August 5, 2024, Incannex Healthcare Inc. announced that FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed. Further information is included in the press release attached as Exhibit 99.1 hereto, which is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Incannex Healthcare Inc., dated August 5, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: August 5, 2024 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 2